1. Home
  2. CALC vs GWH Comparison

CALC vs GWH Comparison

Compare CALC & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • GWH
  • Stock Information
  • Founded
  • CALC 2011
  • GWH 2011
  • Country
  • CALC United States
  • GWH United States
  • Employees
  • CALC N/A
  • GWH N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • CALC Health Care
  • GWH Miscellaneous
  • Exchange
  • CALC Nasdaq
  • GWH Nasdaq
  • Market Cap
  • CALC 26.7M
  • GWH 9.9M
  • IPO Year
  • CALC N/A
  • GWH N/A
  • Fundamental
  • Price
  • CALC $1.74
  • GWH $1.22
  • Analyst Decision
  • CALC Strong Buy
  • GWH Hold
  • Analyst Count
  • CALC 3
  • GWH 5
  • Target Price
  • CALC $16.33
  • GWH $2.10
  • AVG Volume (30 Days)
  • CALC 22.8K
  • GWH 2.2M
  • Earning Date
  • CALC 05-14-2025
  • GWH 05-15-2025
  • Dividend Yield
  • CALC N/A
  • GWH N/A
  • EPS Growth
  • CALC N/A
  • GWH N/A
  • EPS
  • CALC N/A
  • GWH N/A
  • Revenue
  • CALC N/A
  • GWH $4,155,999.00
  • Revenue This Year
  • CALC N/A
  • GWH $179.38
  • Revenue Next Year
  • CALC N/A
  • GWH $175.77
  • P/E Ratio
  • CALC N/A
  • GWH N/A
  • Revenue Growth
  • CALC N/A
  • GWH N/A
  • 52 Week Low
  • CALC $1.43
  • GWH $0.76
  • 52 Week High
  • CALC $5.97
  • GWH $14.10
  • Technical
  • Relative Strength Index (RSI)
  • CALC 47.92
  • GWH 38.02
  • Support Level
  • CALC $1.61
  • GWH $1.16
  • Resistance Level
  • CALC $1.73
  • GWH $2.06
  • Average True Range (ATR)
  • CALC 0.10
  • GWH 0.29
  • MACD
  • CALC -0.01
  • GWH -0.04
  • Stochastic Oscillator
  • CALC 33.33
  • GWH 33.33

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: